Jazz Pharmaceuticals (JAZZ) Enterprise Value Growth (1y) (2011 - 2026)
Jazz Pharmaceuticals (JAZZ) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.95% |
| Dec 31, 2025 | 42.31% |
| Sep 30, 2025 | 40.22% |
| Jun 30, 2025 | 12.24% |
| Mar 31, 2025 | -29.00% |
| Dec 31, 2024 | -60.18% |
| Sep 30, 2024 | -66.07% |
| Jun 30, 2024 | -5.73% |
| Mar 31, 2024 | -23.59% |
| Dec 31, 2023 | -70.88% |
| Sep 30, 2023 | -59.13% |
| Jun 30, 2023 | -80.28% |
| Mar 31, 2023 | -137.94% |
| Dec 31, 2022 | -49.04% |
| Sep 30, 2022 | -24.95% |
| Jun 30, 2022 | 20.21% |
| Mar 31, 2022 | 76.60% |
| Dec 31, 2021 | 44.09% |
| Sep 30, 2021 | 9.46% |
| Jun 30, 2021 | -13.40% |